Update on rotavirus vaccine underperformance in low- to middle-income countries and next-generation vaccines
In the decade since oral rotavirus vaccines (ORV) were recommended by the World Health Organization for universal inclusion in all national immunization programs, significant yet incomplete progress has been made toward reducing the burden of rotavirus in low- to middle-income countries (LMIC). ORVs...
Main Author: | Benjamin Lee |
---|---|
Format: | Article |
Language: | English |
Published: |
Taylor & Francis Group
2021-06-01
|
Series: | Human Vaccines & Immunotherapeutics |
Subjects: | |
Online Access: | http://dx.doi.org/10.1080/21645515.2020.1844525 |
Similar Items
-
Potential impact and cost-effectiveness of injectable next-generation rotavirus vaccines in 137 LMICs: a modelling study
by: Frédéric Debellut, et al.
Published: (2022-01-01) -
Accounting for equity considerations in cost-effectiveness analysis: a systematic review of rotavirus vaccine in low- and middle-income countries
by: Marie-Anne Boujaoude, et al.
Published: (2018-05-01) -
Improving rotavirus vaccine coverage: Can newer-generation and locally produced vaccines help?
by: Jacqueline Deen, et al.
Published: (2018-02-01) -
Defining the Recipe for an Optimal Rotavirus Vaccine Introduction in a High-Income Country in Europe
by: Baudouin Standaert, et al.
Published: (2022-02-01) -
Balancing safety, efficacy and cost: Improving rotavirus vaccine adoption in low- and middle-income countries
by: Anant Bhan, et al.
Published: (2011-12-01)